Developing a pill to treat sickle cell disease.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 38963861.
- Also identified by DOI 10.1126/science.adq3757.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A newly identified epigenetic modifier increases fetal hemoglobin in preclinical studies.
Medical subject headings
- Anemia, Sickle Cell
- Epigenesis, Genetic
- Fetal Hemoglobin
- Antisickling Agents